| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 12,171 | 11,665 | 14,430 | 17,897 | | Cost of Revenue | 4,910 | 5,130 | 5,936 | 7,045 | | | Gross Profit | 7,261 | 6,535 | 8,494 | 10,852 | | | Operating Expenses | | Research Development | 1,684 | 1,495 | 1,743 | 1,933 | | Selling General and Administrative | 7,233 | 9,687 | 9,523 | 9,291 | | Non Recurring |
-
|
-
| 850 |
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (1,656) | (4,647) | (3,622) | (372) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,110) | 511 | 599 | (627) | | Earnings Before Interest And Taxes | (1,368) | (4,136) | (3,023) | (999) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (1,368) | (4,136) | (3,023) | (999) | | Income Tax Expense | 12,126 | (1,772) | (1,195) | (764) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (13,494) | (2,364) | (1,828) | (235) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (13,494) | (2,364) | (1,828) | (235) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($13,494) | ($2,364) | ($1,828) | ($235) |
|
0.51% Nasdaq 
Income Statement
